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Abstract
Objective—To create a clinical consensus statement to address ambiguities and disparities in the 
diagnosis and management of nasal valve compromise (NVC).
Methods—An updated systematic review of the literature was conducted. In addition, a Modified 
Delphi Method was used to refine expert opinion and facilitate a consensus position.
Results—After two rounds of surveys and conference calls, thirty six items reached consensus, 
six items reached near consensus, and ten items reached no consensus. The categories that had the 
greatest percentage of consensus or near consensus items were: definition, history and physical 
examination, outcome measures, and management. Conversely, the categories with greater 
percentage of no consensus items were: adjunctive tests and coding.
Conclusions—The consensus panel agreed that NVC is a distinct clinical entity that is best 
evaluated with history and physical exam findings. Endoscopy and photography are useful but not 
routinely indicated, while radiographic studies are not useful in evaluating NVC. Other objective 
nasal outcome measures may not be useful or accepted for NVC. Nasal steroid medication is not 
useful for treating NVC in the absence of rhinitis, and mechanical treatments may be useful in 
selected patients. Surgical treatment is the primary mode of treatment of NVC, but bill coding 
remains ambiguous and confusing.
Introduction
Nasal valve compromise (NVC) is a distinct and primary cause for symptomatic nasal 
airway obstruction, yet there remain ambiguities and disparities in the diagnosis and 
management. Other etiologies for nasal airway obstruction, either structural or 
inflammatory, may co-exist or mimic the symptoms caused by NVC. Furthermore, current 
procedural terminology (CPT) billing coding schemes for nasal valve surgery are unclear, as 
are the boundaries and overlap with other nasal surgical codes.
The nasal valve, external and internal components, has been described anatomically as the 
cross-sectional area of the nasal cavity with the greatest overall resistance to airflow, thus 
acting as the dominant determinant for nasal inspiration (Fig 1). The external nasal valve is 
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defined as the area in the vestibule, under the nasal ala, formed by the caudal septum, medial 
crura of the alar cartilages, alar rim and nasal sill. The internal nasal valve is located 
approximately 1.3 cm from the nares (nostril opening) and corresponds to the region under 
the upper lateral cartilages, bound medially by the dorsal septum, inferiorly by the head of 
the inferior turbinate, and laterally by the upper lateral cartilage (Fig 2). As air enters these 
narrowed segments, acceleration occurs, leading to a drop in intraluminal pressure 
(Bernoulli's principle). This phenomenon tends to collapse the lateral nasal wall, where 
minor septal deviations, weakened soft tissues, or malformed lateral crura, can have a great 
impact on nasal airflow.
In order to help organize and disseminate information regarding NVC, this consensus panel 
was convened by the American Academy of Otolaryngology—Head Neck Surgery to create 
a clinical consensus statement (CCS). This document reflects information synthesized from 
an organized group of expert opinions in a written document with the purpose of reviewing 
the literature, synthesizing information, and attempting to clarify specific areas of 
controversy or ambiguity.
A recent systematic review1 of the existing primary literature assigned an aggregate grade of 
“observational studies without control” to the present evidence addressing NVC. Because of 
this relative paucity of strong primary studies in the literature, a CCS (as opposed to a 
clinical practice guideline) was considered appropriate in evaluating this clinical problem. 
Therefore, the terms “evidence-based” and “guideline” are not used in the context of this 
document, but rather the findings of this consensus panel are stated as “opinions” or 
“suggestions,” not as “recommendations.”
The primary objective was to develop a CCS on NVC using a Modified Delphi Method, 




The recent evidence review on nasal valve repair1 was used to identify clinically important 
gaps in knowledge. To ensure full review of the literature, the consensus panel chair (JSR) 
updated the systematic review using the same search terms and databases as the original 
review.1 This updated literature search included articles in PubMed from 9/2007 through 
9/2009. The date criteria were designed to overlap with the initial systematic review, which 
reviewed the literature published through 8/2007. This overlap ensured inclusion of late 
entries into the literature databases. Only articles published in English were reviewed. No 
other systematic search limitations were used.
Delphi Method
Overview—The consensus panel used the Delphi Method defined as “a multiple iteration 
technique usually meant to be anonymous with the purpose of refining the expert opinion 
and ultimately arrive at a combined or consensual position.”2 The original Delphi Method 
was developed in the 1950's by the RAND Corporation. Over time, the method has been 
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modified and improved, especially with new technology, however the basic process has 
remained consistent. The method enables equal input from each panel member and reduces 
undue influence of a minority of participants. The CCS development process (Fig 3) 
consisted of:
1. Expert Panel appointment and CCS methods review.
2. Survey development.
3. Panel Surveys (two). Each round included a teleconference discussion of 
ambiguous items requiring clarification and repeat of the survey.
4. Analyses and interpretation.
Expert Panel
Eight panel members were selected for their work in related fields and their valued expert 
opinion. The panel represented a wide cross section of subject matter experts mainly 
representing Facial Plastic Surgery as well as Rhinology, Sleep Medicine and General 
Otolaryngology - Head and Neck Surgery. The chair identified and recruited the panel 
members, and sought input in the process from panel members.
After panel recruitment was completed, an introductory teleconference oriented the group to 
the topic and consensus process. Prior to the call, literature was disseminated electronically 
to help guide discussion.1,3-8 The nasal valve repair systematic review was discussed.1 A 
qualitative group survey was conducted first, which consisted of open-ended questions to 
help determine the focus of the consensus statement. This survey concentrated on areas of 
controversy, knowledge gaps, variances in practice, and disparities of opinion. Topics for the 
CCS were brainstormed, reviewed, and refined, including:
1. Definition of NVC
2. History & physical examination findings





The first formal survey was developed to cover the items identified above. This survey used 
a qualitative structure with free text responses to open-ended questions covering the 
following categories: definition, history and physical examination, adjunctive tests, outcome 
measures, management, and coding. After reviewing the responses, the chair, in conjunction 
with a subgroup of the panel, formulated targeted questions on NVC.2 To avoid bias, 
questions were worded in neutral terms. Items were reviewed with the subgroup for content, 
clarity, neutrality, and were refined as needed. After the first full panel survey, the survey 
questions were reviewed with the panel for refinement to reduce ambiguity for the second 
full panel survey.
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The survey instrument included statements to which the panel members responded 
according to their level of agreement on a Likert scale. The nine-point Likert scale ranged 
from one representing “strongly disagree” to nine representing “strongly agree,” and five 
was defined as “neutral”. (Fig 4). Other instrument items required a best response answer 
(e.g., which would be the most appropriate code for a described procedure). The survey 
included the published description of each code offered as a choice.9
Panel Surveys
The panel was surveyed twice using web-based software (i.e., SurveyMonkey, Menlo Park, 
CA) in order to protect confidentiality and to limit the possibility of bias. Email addresses 
were collected strictly for administrative purposes and to track panelist responses, however 
all administrative data collected were de-identified prior to the data being presented to the 
chair.
Responses were sent to the chair for analysis once each panelist had completed the survey. 
The responses were then summarized and distributed among the group for review via a 
conference call. Throughout the process, conference calls were designed to provide the 
opportunity for the chair and panelists to identify ambiguity in the statements, revise 
wording, and to answer any outstanding questions about the process. They were also used to 
reconcile any statements that were found to have no consensus or to be irrelevant.
Analyses and Interpretation
Statistical analyses were performed for each survey question. Likert scales were reported 
with the mean, mode, median, interquartile range (IQR), and full range. The individual items 
were grouped by the original qualitative survey designation: definition, history and physical 
examination, adjunctive tests, outcome measures, management, and coding.
For the Likert scales, consensus was defined as responses clustered within two Likert rating 
points of the mean response with no more than one outlier. Near consensus occurred when 
there was a cluster around the mean response with two outliers. No consensus was 
considered when the consensus or near consensus criteria were not met (Fig 4). For the 
patient scenarios, consensus was reached if an individual response was chosen by at least 
75% of the panelists.
Results
Systematic Review
No new original research studies that met search criteria were found during the time period 
between the systematic review1 and this CCS document, however, one additional systematic 
review was found and reviewed.10
Survey Results
After the qualitative portion of the survey design was completed, a total of 53 questions were 
created and administered. After the first panel survey, 27 items reached consensus, 9 items 
reached near consensus, and 17 items reached no consensus. After the review, survey 
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revision, and second panel survey, 36 items reached consensus, 6 items reached near 
consensus, and 10 items reached no consensus (Tables 1-6). The categories that had the 
greatest percentage of consensus or near consensus items were: definition, history and 
physical examination, outcome measures, and management. Conversely, the categories with 
a greater percentage of no consensus items were: adjunctive tests and coding.
Definition
Consensus was achieved with agreement or strong agreement that NVC is a distinct clinical 
entity separate from other anatomic reasons for nasal obstruction. The panel met consensus 
with agreement or strong agreement that NVC can be caused by collapse of the alar rim or 
lateral nasal wall, collapse of the cartilaginous portion of the nasal dorsum, a high septal 
deviation, hypertrophied inferior turbinate, severely ptotic nasal tip, wide nasal columella, 
and a caudal septal deviation (Table 1). The panel did not meet consensus on whether an 
inferior septal spur can cause NVC, with scores ranging from strongly disagree to strongly 
agree.
History & Physical
The panel met consensus with strong agreement that the main symptom of NVC is 
decreased airflow as reported by the patient and with agreement that NVC can adversely 
affect sleep (Table 2). The panel also met consensus with agreement or strong agreement 
with the following: anterior rhinoscopy can be adequate for an intranasal evaluation of the 
nasal valve, weak or malformed nasal cartilages can be diagnosed on physical examination, 
inspiratory collapse of the lateral nasal wall or alar rim is consistent with NVC, and 
increased nasal obstruction associated with deep inspiration is consistent with NVC. The 
panel met consensus with agreement that, with valve stabilization maneuvers, a combination 
of audible and subjective improvement or subjective improvement alone were consistent 
with NVC, and they met near consensus that audible improvement alone was consistent with 
NVC. While a majority of panelists disagreed or strongly disagreed that nasal obstruction 
associated with deep expiration may be consistent with NVC, no consensus was reached 
because three panelists were neutral or agreed with this statement.
Adjunctive tests
With regard to adjunctive tests in the evaluation of NVC, there was a consensus strong 
disagreement that there is currently a gold standard test to diagnose NVC (Table 3). Nasal 
endoscopy and nasal photography were both deemed useful but not routinely required. 
Specifically, the panel met consensus with agreement that nasal endoscopy is useful to rule 
out other obstructing pathology, but the panel did not meet consensus on whether endoscopy 
is routinely indicated for this purpose. There was near consensus that nasal endoscopy can 
be useful for diagnosing NVC. Similarly, the panel met consensus with agreement that nasal 
photography is useful for documenting an external nasal deformity that may be consistent 
with NVC, but there was no consensus on whether photography was routinely necessary. 
There was a consensus of weak agreement that a trial of adult nasal dilator strips (e.g., 
Breathe Right® strips, GlaxoSmithKline, Middlesex, United Kingdom) is useful for 
confirming the diagnosis of NVC.
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There was less enthusiasm about the role of radiographic studies (e.g. computed tomography 
(CT) or magnetic resonance imaging (MRI)) in the evaluation of NVC. There was consensus 
with strong disagreement that radiographic studies are routinely indicated to rule out other 
reasons for symptomatic nasal obstruction not caused by NVC, but there was no consensus 
about whether radiographic studies are useful for this purpose. There was consensus of 
strong disagreement that magnetic resonance imaging is useful for confirming the diagnosis 
of NVC, and there was no consensus but general disagreement that computed tomography 
(CT) scan is useful for this purpose.
The two items in the adjunctive test category that relate to acoustic rhinometry and 
rhinomanometry were the only items that did not have a 100% response rate. Only two out 
of the eight panelists responded to these items which had the caveat of “answer only if you 
have experience with this test, otherwise leave blank.” Because of this low response rate, 
these two items were categorized in the no consensus group regardless of score pattern.
Outcome measures
The panel met consensus with general agreement that various patient-reported outcomes 
(e.g., visual analog scales, satisfaction measures, quality of life scales) are valid indicators of 
successful intervention. There was no consensus whether ad hoc patient satisfaction 
questionnaires are valid indicators of success (Table 4). The panel met near consensus on 
three statements about the relative importance of patient-reported outcome measures versus 
objective measures in measuring success of an intervention, with a general conclusion that 
patient-oriented outcome measures are more important than objective measures.
Management and coding
With regard to management of NVC, the panel met consensus of strong disagreement that a 
trial of nasal steroids is indicated for patients with NVC who do not have allergy symptoms 
or physical exam findings consistent with rhinitis (Table 5). There was consensus with 
agreement that nasal strips, stents or cones can be used therapeutically for NVC for some 
patients.
The panel met consensus with uniformly strong agreement that a surgical procedure that is 
targeted to support the lateral nasal wall/alar rim is a distinct entity from procedures that 
correct a deviated nasal septum or hypertrophied turbinate. There was consensus with 
agreement that, in some cases, septoplasty and/or turbinate surgery can treat NVC without 
surgery to support the lateral nasal wall/alar rim.
For the patient case scenarios, only two of the five coding questions reached consensus of 
agreement after the Delphi rounds even though this topic was discussed heavily on the 
conference calls between the two rounds (Tables 5-7).
Discussion
The purpose of this CCS was to help distinguish NVC from other disease entities that may 
cause symptomatic nasal airway obstruction. Furthermore, it was our desire to distill expert 
opinions on current diagnosis and management strategies for NVC. Finally, we hoped to 
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uncover areas of ambiguity and disagreement that would set priorities in need of clarification 
and for future research.
Systematic Review of Literature
In the review by Rhee et al,1 the majority of studies used an uncontrolled case series study 
design, with the exception of two well-controlled cohort studies that specifically compared 
one surgical technique to another (also called “outcomes study design”).1 Using published 
evidence-grading guidelines for evidence grading from A (strongest evidence) to D (weakest 
evidence),11 the review authors assigned an aggregate grade C for the overall strength of 
evidence regarding the surgical management of NVC. A grade of C indicates the evidence 
overall is represented almost exclusively by uncontrolled case series. To clarify, evidence 
grading speaks to the strength or quality of the study design, but not to the results of a study.
In fact, there appeared to be a consistent finding of beneficial effects of nasal valve surgery 
in all reviewed studies. The effect size, however, was difficult to quantify as an aggregate 
given the heterogeneity of the outcome measures. Also, many of the studies had other 
adjunctive procedures performed concurrently. The impact of these other simultaneous 
procedures on the correction of nasal airway obstruction (e.g., septoplasty, turbinate surgery, 
and sinus surgery) could not be separated from those procedures specifically targeted for 
other components of the nasal valve.
Similar findings and conclusions were presented in another systematic review by Spielman 
et al.10 The review reported that nasal valve surgery research is too focused on the technique 
rather than patient outcomes. Additionally, the review pointed out the deficiencies in the use 
of objective measures for assessing nasal airflow to evaluate the efficacy of treatment.
The apparent beneficial clinical effect seen consistently across most of the published studies 
suggests the importance of surgical management for NVC. However, the lack of controlled 
studies leaves open the possibility that the observed surgical effects were a result of study 
biases. It is important to be explicit that lack of strong evidence for surgical management is 
entirely different from evidence that surgery is not helpful. The lack of evidence simply 
means that it has not been studied rigorously. Currently, there is existing evidence, albeit 
mostly uncontrolled study designs, that suggests a strong benefit of surgery. In light of this 
situation where there appears to be an effect consistently across studies, but the strength of 
those studies is weak, the CCS was deemed an important step to help define and clarify 
some of the clinical issues.
Delphi process outcomes
Consensus was achieved in many areas of concern – diagnosis, physical exam findings, 
outcome measures, and general management strategies. The areas with the most ambiguity 
were the use of adjunctive tests and coding of the procedures which relate to 
preauthorizations and payments for services.
The panel strongly agreed that the diagnosis of NVC is mainly a clinical one, based on 
careful history-taking and physical exam findings. External structural nasal abnormalities at 
the level of the nostril and internal nasal valve must be carefully examined in addition to the 
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intranasal components of the septum, turbinates, and nasal mucosa. Visible inspiratory 
collapse of the lateral nasal wall or nostril is diagnostic for NVC, though not necessarily 
always the target for therapy.
As noted earlier, slight and subtle anatomic abnormalities of multiple external or internal 
structures of the nose can contribute to NVC. Depending on the anatomic area of concern, 
the targeted therapy may not be “lateral nasal wall surgery” (i.e., vestibular stenosis repair, 
CPT code 30465). NVC can also be managed by septoplasty, turbinate surgery or 
rhinoplasty (elevation or modification of the nasal tip or nasal base in areas of nasal airway 
interface). Similarly, lateral nasal wall surgery (e.g., spreader grafts, suspension sutures, alar 
batton grafts) may be insufficient alone to correct the nasal airway without concomitant 
turbinate or septal surgery. The clinician should make a judgment, in conjunction with the 
patient's preference as to which of the anatomic structures needs to be addressed to best 
manage NVC based on individual patient factors. This judgment is mainly based upon exam 
findings coupled with patient-reported symptoms preferably including disease-specific 
quality of life (QOL) measures or other scales.
Existing adjunctive diagnostic tests are controversial in their usefulness for NVC diagnosis 
and this ambiguity is reflected in our Delphi findings for this category. It should be noted 
that lack of consensus only means there was different levels of agreement about the role of 
certain tests; it does not mean any given test is never useful in evaluating NVC. Currently, 
there is a lack of a “gold standard” objective test for NVC. Some objective measurement 
tools, such as acoustic rhinometry or rhinomanometry, are not universally available or 
accepted and their limitations in terms of clinical usefulness and unfamiliarity have made 
these tools less appealing to clinicians. The unfamiliarity of these tools was reflected in our 
panel responses with only two out of the eight panelists having some expertise with these 
tests. The role of radiographic tests such as CT or MRI is mainly to rule out other disease 
processes (e.g., sinusitis, nasal polyps, neoplasms) that may impact nasal airflow. 
Photographic documentation of NVC was noted sometimes to be useful but not necessary to 
evaluate NVC. The dynamic nature of NVC and the fact that sometimes the external nasal 
findings are subtle may not lend themselves to photographic capture at the time of the office 
visit. Finally, nasal endoscopy was felt to be useful, but there were discrepant opinions about 
whether it is routinely indicated. In contrast, radiographic studies were not considered 
useful, except possibly to rule out other obstructing lesions when indicated.
The topic of surgical management of NVC, as it relates to the external nasal deformities, was 
made purposely broad in its scope. The goal of this CCS was not to evaluate the individual 
procedures that target correction of the nostril opening or lateral nasal wall (e.g., spreader 
grafts, alar batten grafts, suspension sutures, and other procedures). Nevertheless, our 
panelists agree that surgical correction of the lateral nasal wall or nostril opening clearly has 
a role in treating NVC, and it is indicated when septal and/or turbinate surgery is not 
sufficient alone or are not etiologic factors for the clinical problem of NVC. The use of 
alternative mechanical stents, such as nasal cones or nasal dilator strips, has a role in some 
patients as diagnostic and therapeutic strategies. Patients who are poor surgical candidates 
due to underlying medical co-morbidities or those who do not wish to undergo surgery may 
find the use of these mechanical stents helpful to treat the lateral nasal wall collapse. 
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However, these devices are not always effective. For example, the patient should be made 
aware that intranasal deformities such as a severely deviated nasal septum or hypertrophied 
inferior turbinate will not be addressed in using these mechanical stents which may mitigate 
the effectiveness of the stents.
The confusion over present CPT coding schemes is exemplified by the lack of consensus by 
our panel in three of the five patient surgery coding scenarios and statements (Tables 5, 6). 
On the conference calls, there was strong consensus on the appropriate surgical procedures 
that would address the presented patient problem; however the translation of the procedures 
to appropriate CPT coding was deemed difficult. This paradox is exemplified in the case 
noted in the near consensus group (Table 6). Consensus was reached in the need for 
concomitant septoplasty and lateral nasal wall repair; however, the actual coding choices 
were without consensus. Specifically, if a caudal septoplasty and right alar rim graft using 
septal cartilage was used to treat NVC, there was consensus that the code should include 
unilateral lateral nasal wall reconstruction (30465-52) but there was confusion about 
whether it should include septoplasty (30520) or cartilage graft from the nasal septum 
(20912). Various factors (e.g., local coding practice patterns, individual interpretation of past 
coding recommendations, and incomplete descriptions of existing codes) appeared to affect 
coding choices.
Furthermore, this CCS process brought to light other deficiencies of the existing CPT coding 
schemes for NVC: lack of differentiation between functional versus cosmetic-intended 
procedures and between primary versus revision surgery. A revised coding scheme is 
suggested that would more accurately depict the surgical maneuvers that are needed to 
address the multi-structural components of the impaired nasal airway due to NVC.
Another important area of consensus was reached in the topic of the use of nasal steroid 
spray as it relates to NVC. NVC as noted earlier is a distinct, anatomical, mechanical source 
for nasal airway obstruction. The routine and required use of nasal steroid spray as a 
prerequisite for surgical candidacy for NVC is uniformly not recommended by our panelists 
in the absence of rhinitis. If the history and physical examination are consistent with NVC 
without rhinitis, the suggested treatment is targeted surgical management (or the use of 
mechanical stents in selected cases).
Some of the limitations of this study include the relatively small group of experts weighted 
on the subspecialty of facial plastic surgery, the physician-only based opinions, the intrinsic 
limitations of the existing body of literature, and the low strength of opinion-based evidence. 
Nevertheless, this panel represented a diverse set of relevant clinical specialties, with a focus 
of relevance on patients and clinical practice, while using a rigorous method to measure 
opinion consensus on topics not fully addressed in the medical literature. We have developed 
opinions and suggestions as part of this CCS that will hopefully be used by surgeons, 
training programs, and other healthcare stakeholders for the diagnosis and management of 
NVC.
Future directions for development are wide ranging. Further scientific inquiry into 
mechanisms of NVC and testing of therapeutic options are needed. Development and testing 
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of objective measures of NVC and treatment outcome will be helpful. Improvement in 
surgical techniques and mechanical devices will facilitate better patient care. On a more 
immediate level, understanding of the coding ambiguities and clarification of the coding 
schemes is needed. For example, a survey of coding practices among a large sample of nasal 
valve surgeons would serve to test the validity of the coding confusion and ambiguity 
highlighted in this CCS.
Summary
The panel found a consistent literature of benefit of surgical treatment of NVC, but the 
evidence relied mostly on uncontrolled studies. The panel generally agreed on the anatomic 
and functional features that define the distinct clinical entity of NVC and that it is best 
evaluated with history and physical exam findings. Endoscopy and photography are useful 
but not always routinely indicated, while radiographic studies are not felt to be useful in 
evaluating NVC per se. Other objective nasal outcome measures are not routinely used and 
may not be useful for this particular nasal condition. Nasal steroid medication is not useful 
for treating NVC in the absence of rhinitis, and mechanical treatments may be useful in 
selected patients. Surgical treatment is the primary mode of treatment of NVC, but bill 
coding remains ambiguous and confusing.
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Figure 1. External and internal components of the nasal valve
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Figure 2. Anatomy of the internal nasal valve
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Figure 3. Consensus development process
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Figure 4. Examples of NVC questions and responses on Likert scale
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Table 6
Management and Coding: Patient case scenarios
Consensus A healthy 25 year old patient has collapse of the right nasal ala with inspiration with a weak lower latéral cartilage on that 
side. Patient is also noted to have a caudal septal deviation to the right narrowing the right nasal vestibule. The inferior 
turbinate is normal and nonobstructive. The next step in management would be: Trial of nasal steriods, Trial of Adult Nasal 
Strips (e.g. Breathe Right Strips), Surgical Intervention.
Answer Options Response Percent Response Count
Trial of nasal steroids 0.00% 0
Trial of Adult Nasal Strips (e.g., Breathe 
Right® Strips)
25.00% 2
Surgical intervention 75.0% 6
A patient has a curved midvault, deviated nasal bones, deviated septum, normal turbinate size and symptoms and physical 
exam findings consistent with NVC. Patient undergoes an external rhinoplasty approach with insertion of bilateral spreader 
grafts using septal cartilage, septoplasty, bilateral lateral osteotomies and reconstitution of the nasal tip complex using a 
dome suture and caudal strut. This procedure would be best coded by:
Answer Options Response Percent Response Count
30420 87.5% 7
30465 +20912 12.5% 1
Near Consensus If a caudal septoplasty + right alar rim graft using septal cartilage was chosen, how would this be coded:
Answer Options Response Percent Response Count
30520 + 30465 with 52 modifier 62.50% 5
30420 12.50% 1
30465 with 52 modifier + 20912 25.0% 2
No Consensus A patient has a curved midvault, straight nasal bones, deviated septum, normal turbinate size, and symptoms and physical 
exam findings consistent with NVC. Patient undergoes an external rhinoplasty approach with insertion of bilateral spreader 
grafts using septal cartilage, septoplasty, and the reconstitution of the nasal tip complex using a dome suture. This procedure 
would be best coded by:
Answer Options Response Percent Response Count
30465 12.5% 1
30420 50.0% 4
30465 + 20912 37.5% 3
A 65 year old patient has a severely ptotic nasal tip with bilateral nasal obstruction symptoms. The nasal septum is midline 
and the turbinates are normal. Raising the ptotic tip on exam creates marked symptomatic relief of the nasal obstruction 
symptoms. Patient undergoes a nasal procedure that rotates the tip using a septal cartilage caudal strut graft and other tip 
procedures. No alar rim/batten grafts are placed. This procedure would be best coded by:
Answer Options Response Percent Response Count
30420 0 0
30465 + 20912 62.50% 5
30400 + 20912 37.5.0% 3
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Table 7
Current Procedural Terminology (CPT) Code Definitions9
Code Definition
30400 Rhinoplasty, primary; lateral and alar cartilages and/or elevation of nasal tip
30420 Rhinoplasty, primary; including major septal repair
30465 Repair of nasal vestibular stenosis (e.g. spreader grafting, lateral nasal wall reconstruction) (30465 is used to report a bilateral 
procedure. For unilateral procedure, use modifier 52)
20912 Cartilage graft; nasal septum
30520 Septoplasty or submucous resection, with or without cartilage scoring, contouring replacement with graft
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